Fatal embolic myocardial infarction after systemic thrombolysis for stroke

Cerebrovascular Diseases

Volumn 22, Issue 2-3, 2006, Pages 213-214

  Meissner, Wassilios ^a,b   Lempert, Thomas ^a   Saeuberlich Knigge, Sabine ^a   Bocksch, Wolfgang ^a   Pape, Ulrich Frank ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CATECHOLAMINE; FIBRINOLYTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

CEREBROVASCULAR ACCIDENT; FATAL OUTCOME; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33746364151     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093812     Document Type: Article

References (15)

1. The NINDS rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Mar J, Begiristain JM, Arrazola A: Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis 2005;20:193-200.
3. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, Levine SR, Broderick JP, Kwiatkowski TG, Frankel M, Brott TG, Walker MD: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-890.
4. Davalos A: Thrombolysis in acute ischemic stroke: successes, failures, and new hopes. Cerebrovasc Dis 2005;20(suppl 2):135-139.
5. Bogousslavsky J, Van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
6. Olsen TS, Skriver EB, Herning M: Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke 1985;16:459-466.
7. Sen S, Laowatana S, Lima J, Oppenheimer SM: Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry 2004;75:1421-1425.
8. MacKenzie JM: Are all cardio-embolic strokes embolic? An autopsy study of 100 consecutive acute ischaemic strokes. Cerebrovasc Dis 2000;10:289-292.
9. Caplan LR: Of birds and nests and brain emboli. Rev Neurol (Paris) 1991;147:265-273.
10. Abascal VM, Kasznica J, Aldea G, Davidoff R: Left atrial myxoma and acute myocardial infarction: a dangerous duo in the thrombolytic agent era. Chest 1996;109:1106-1108.
11. Perera R, Noack S, Dong W: Acute myocardial infarction due to septic coronary embolism. N Engl J Med 2000;342:977-978.
12. Lanza GM, Berman BJ, Tanuchi M: Multifocal coronary thromboembolism from a left ventricular thrombus. N Engl J Med 1999;341:1083-1084.
13. Koller PT, Arom KV: Thrombolytic therapy of left-sided prosthetic valve thrombosis. Chest 1995;108:1683-1689.
14. Stafford PJ, Strachan CJ, Vincent R, Chamberlain DA: Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ 1989;299:1310-1312.
15. Sloan MA, Price TR, Terrin ML, Forman S, Gore JM, Chaitman BR, Hodges M, Mueller H, Rogers WJ, Knatterud GL, Braunwald E: Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction: the TIMI-II pilot and randomized clinical trial combined experience. Stroke 1997;28:1107-1114.